Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Julphar
Daiichi Sankyo
Express Scripts
Healthtrust
Chinese Patent Office
Federal Trade Commission
Harvard Business School

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022408

« Back to Dashboard

NDA 022408 describes NATROBA, which is a drug marketed by Parapro Llc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the NATROBA profile page.

The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.
Summary for 022408
Tradename:NATROBA
Applicant:Parapro Llc
Ingredient:spinosad
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022408
Suppliers and Packaging for NDA: 022408
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATROBA spinosad SUSPENSION;TOPICAL 022408 NDA Allegis Pharmaceuticals, LLC 28595-570 N 28595-570-04
NATROBA spinosad SUSPENSION;TOPICAL 022408 NDA ParaPRO LLC 52246-929 N 52246-929-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;TOPICALStrength0.9%
Approval Date:Jan 18, 2011TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 25, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:NATROBA TOPICAL SUSPENSION IS A PEDICULICIDE INDICATED FOR THE TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS SIX (6) MONTHS OF AGE AND OLDER.
Patent:➤ Try a Free TrialPatent Expiration:Jun 22, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
Patent:➤ Try a Free TrialPatent Expiration:Jul 2, 2021Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Fuji
Teva
Moodys
Deloitte
Cerilliant
Chubb
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.